Production (Stage)
Cabaletta Bio, Inc.
CABA
$1.92
-$0.015-0.78%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 42.50% | 43.28% | 64.88% | 66.75% | 54.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 56.58% | 67.61% | 68.84% | 64.34% | 47.57% |
| Operating Income | -56.58% | -67.61% | -68.84% | -64.34% | -47.57% |
| Income Before Tax | -64.91% | -71.21% | -66.71% | -56.60% | -37.55% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -64.91% | -71.21% | -66.71% | -56.60% | -37.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -64.91% | -71.21% | -66.71% | -56.60% | -37.55% |
| EBIT | -56.58% | -67.61% | -68.84% | -64.34% | -47.57% |
| EBITDA | -57.14% | -68.54% | -70.15% | -65.82% | -48.46% |
| EPS Basic | -48.12% | -41.44% | -25.38% | -9.79% | 5.23% |
| Normalized Basic EPS | -48.14% | -41.46% | -25.39% | -9.79% | 5.24% |
| EPS Diluted | -48.08% | -41.47% | -25.43% | -9.82% | 5.50% |
| Normalized Diluted EPS | -48.14% | -41.46% | -25.39% | -9.79% | 5.24% |
| Average Basic Shares Outstanding | 12.34% | 20.95% | 30.16% | 40.58% | 43.85% |
| Average Diluted Shares Outstanding | 12.34% | 20.95% | 30.16% | 40.58% | 43.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |